Literature DB >> 6198567

Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure.

B Jackson, P G Matthews, B P McGrath, C I Johnston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198567     DOI: 10.1016/s0140-6736(84)92149-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Interventions in chronic renal failure.

Authors:  J R Curtis
Journal:  BMJ       Date:  1990-09-29

2.  New developments in renin and hypertension.

Authors:  N J Samani
Journal:  BMJ       Date:  1991-04-27

3.  Lisinopril pharmacokinetics in chronic renal failure.

Authors:  B Jackson; R B Cubela; E L Conway; C I Johnston
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

Review 4.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Percutaneous Transluminal Revascularization following an Angiotensin Receptor Blocker: Successful Treatment for Flash Pulmonary Edema and Hyponatremic Hypertensive Syndrome.

Authors:  Leping Shao; Yanxia Gao; Yan Xu; Yanhua Lang
Journal:  Cardiorenal Med       Date:  2012-06-14       Impact factor: 2.041

6.  NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011.

Authors:  Soo Min Jang; Jennifer Cerulli; Darren W Grabe; Chester Fox; Joseph A Vassalotti; Alexander J Prokopienko; Amy Barton Pai
Journal:  Prev Chronic Dis       Date:  2014-12-18       Impact factor: 2.830

Review 7.  Endovascular Management of Atherosclerotic Renal Artery Stenosis: Post-Cardiovascular Outcomes in Renal Atherosclerotic Lesions Era Winner or False Alarm?

Authors:  Evridiki Karanikola; Georgios Karaolanis; George Galyfos; Emmanuel Barbaressos; Viktoria Palla; Konstantinos Filis
Journal:  Vasc Specialist Int       Date:  2017-03-31

Review 8.  The diagnosis and management of renovascular disease: a primary care perspective. Part II. Issues in management.

Authors:  Michael J Bloch; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.